Clinical Trial Update: DNA in Predicting Response After Systemic Therapy in Women With Metastatic Breast Cancer

View source ↗

Summary

A completed clinical trial investigating whether DNA markers can predict response after systemic therapy in women with metastatic breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Breast Cancer | Status: COMPLETED | Results posted: 2019-07-26